HEADER HYDROLASE/HYDROLASE INHIBITOR 20-MAY-09 3HIV TITLE CRYSTAL STRUCTURE OF SAPORIN-L1 IN COMPLEX WITH THE TRINUCLEOTIDE TITLE 2 INHIBITOR, A TRANSITION STATE ANALOGUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: VACUOLAR SAPORIN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.2.22; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SAPONARIA OFFICINALIS; SOURCE 3 ORGANISM_COMMON: COMMON SOAPWORT; SOURCE 4 ORGANISM_TAXID: 3572; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSITION STATE, RIBOSOME INACTIVATING PROTEINS, RIPS, HYDROLASE, KEYWDS 2 PLANT DEFENSE, PROTEIN SYNTHESIS INHIBITOR, TOXIN, HYDROLASE- KEYWDS 3 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.HO,M.B.STURM,S.C.ALMO,V.L.SCHRAMM REVDAT 6 21-FEB-24 3HIV 1 REMARK REVDAT 5 01-NOV-17 3HIV 1 REMARK REVDAT 4 13-JUL-11 3HIV 1 VERSN REVDAT 3 21-APR-10 3HIV 1 SEQRES DBREF REMARK SITE REVDAT 2 15-DEC-09 3HIV 1 JRNL REVDAT 1 08-DEC-09 3HIV 0 JRNL AUTH M.C.HO,M.B.STURM,S.C.ALMO,V.L.SCHRAMM JRNL TITL TRANSITION STATE ANALOGUES IN STRUCTURES OF RICIN AND JRNL TITL 2 SAPORIN RIBOSOME-INACTIVATING PROTEINS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 20276 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19920175 JRNL DOI 10.1073/PNAS.0911606106 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0066 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 24447 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1297 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.19 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1208 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 56 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4030 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 150 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.71000 REMARK 3 B22 (A**2) : -1.54000 REMARK 3 B33 (A**2) : 1.24000 REMARK 3 B12 (A**2) : 1.88000 REMARK 3 B13 (A**2) : -1.67000 REMARK 3 B23 (A**2) : -1.87000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.322 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.213 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.166 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.545 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4277 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5839 ; 1.625 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 514 ; 6.054 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 191 ;42.472 ;25.079 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 702 ;15.589 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;23.992 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 673 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3174 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2557 ; 0.553 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4140 ; 1.017 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1720 ; 1.829 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1698 ; 3.026 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 35 A 257 REMARK 3 ORIGIN FOR THE GROUP (A): 31.5070 58.9720 49.5650 REMARK 3 T TENSOR REMARK 3 T11: 0.1798 T22: 0.1629 REMARK 3 T33: 0.1138 T12: 0.0103 REMARK 3 T13: 0.0019 T23: 0.0104 REMARK 3 L TENSOR REMARK 3 L11: 1.0771 L22: 0.9155 REMARK 3 L33: 0.9292 L12: 0.4345 REMARK 3 L13: 0.6005 L23: 0.0795 REMARK 3 S TENSOR REMARK 3 S11: -0.0378 S12: -0.0151 S13: 0.0099 REMARK 3 S21: 0.0232 S22: -0.0458 S23: -0.1046 REMARK 3 S31: -0.0136 S32: -0.0219 S33: 0.0837 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 35 B 257 REMARK 3 ORIGIN FOR THE GROUP (A): 26.3210 30.9140 24.6100 REMARK 3 T TENSOR REMARK 3 T11: 0.1270 T22: 0.1450 REMARK 3 T33: 0.1735 T12: -0.0122 REMARK 3 T13: 0.0306 T23: 0.0249 REMARK 3 L TENSOR REMARK 3 L11: 0.3961 L22: 2.1831 REMARK 3 L33: 1.3020 L12: 0.2204 REMARK 3 L13: 0.4845 L23: 0.7360 REMARK 3 S TENSOR REMARK 3 S11: 0.0069 S12: 0.0596 S13: 0.0148 REMARK 3 S21: 0.0318 S22: 0.0611 S23: -0.3089 REMARK 3 S31: 0.0402 S32: 0.0949 S33: -0.0681 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3HIV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAY-09. REMARK 100 THE DEPOSITION ID IS D_1000053186. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.081 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25749 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 51.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5730 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.35700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG2000MME, 0.1M SODIUM ACETATE, REMARK 280 0.4M POTASSIUM THIOCYANATE, PH 5.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 258 REMARK 465 ASN A 259 REMARK 465 ASN B 258 REMARK 465 ASN B 259 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 211 CA - CB - CG ANGL. DEV. = 15.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 71 13.83 -150.37 REMARK 500 GLU A 194 -127.27 41.33 REMARK 500 GLU A 196 117.15 -164.60 REMARK 500 ASN B 71 13.39 -152.22 REMARK 500 VAL B 172 -64.22 -99.56 REMARK 500 GLU B 194 -138.86 56.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TXN A 258 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TXN B 258 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HIO RELATED DB: PDB REMARK 900 RELATED ID: 3HIQ RELATED DB: PDB REMARK 900 RELATED ID: 3HIS RELATED DB: PDB REMARK 900 SAME PROTEIN, APO FORM REMARK 900 RELATED ID: 3HIT RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH DINUCLEOTIDE INHIBITOR REMARK 900 RELATED ID: 3HIW RELATED DB: PDB DBREF 3HIV A 1 259 UNP Q2QEH4 Q2QEH4_SAPOF 22 280 DBREF 3HIV B 1 259 UNP Q2QEH4 Q2QEH4_SAPOF 22 280 SEQRES 1 A 259 VAL ILE ILE TYR GLU LEU ASN LEU GLN GLY THR THR LYS SEQRES 2 A 259 ALA GLN TYR SER THR PHE LEU LYS GLN LEU ARG ASP ASP SEQRES 3 A 259 ILE LYS ASP PRO ASN LEU HIS TYR GLY GLY THR ASN LEU SEQRES 4 A 259 PRO VAL ILE LYS ARG PRO VAL GLY PRO PRO LYS PHE LEU SEQRES 5 A 259 ARG VAL ASN LEU LYS ALA SER THR GLY THR VAL SER LEU SEQRES 6 A 259 ALA VAL GLN ARG SER ASN LEU TYR VAL ALA ALA TYR LEU SEQRES 7 A 259 ALA LYS ASN ASN ASN LYS GLN PHE ARG ALA TYR TYR PHE SEQRES 8 A 259 LYS GLY PHE GLN ILE THR THR ASN GLN LEU ASN ASN LEU SEQRES 9 A 259 PHE PRO GLU ALA THR GLY VAL SER ASN GLN GLN GLU LEU SEQRES 10 A 259 GLY TYR GLY GLU SER TYR PRO GLN ILE GLN ASN ALA ALA SEQRES 11 A 259 GLY VAL THR ARG GLN GLN ALA GLY LEU GLY ILE LYS LYS SEQRES 12 A 259 LEU ALA GLU SER MET THR LYS VAL ASN GLY VAL ALA ARG SEQRES 13 A 259 VAL GLU LYS ASP GLU ALA LEU PHE LEU LEU ILE VAL VAL SEQRES 14 A 259 GLN MET VAL GLY GLU ALA ALA ARG PHE LYS TYR ILE GLU SEQRES 15 A 259 ASN LEU VAL LEU ASN ASN PHE ASP THR ALA LYS GLU VAL SEQRES 16 A 259 GLU PRO VAL PRO ASP ARG VAL ILE ILE LEU GLU ASN ASN SEQRES 17 A 259 TRP GLY LEU LEU SER ARG ALA ALA LYS THR ALA ASN ASN SEQRES 18 A 259 GLY VAL PHE GLN THR PRO LEU VAL LEU THR SER TYR ALA SEQRES 19 A 259 VAL PRO GLY VAL GLU TRP ARG VAL THR THR VAL ALA GLU SEQRES 20 A 259 VAL GLU ILE GLY ILE PHE LEU ASN VAL ASP ASN ASN SEQRES 1 B 259 VAL ILE ILE TYR GLU LEU ASN LEU GLN GLY THR THR LYS SEQRES 2 B 259 ALA GLN TYR SER THR PHE LEU LYS GLN LEU ARG ASP ASP SEQRES 3 B 259 ILE LYS ASP PRO ASN LEU HIS TYR GLY GLY THR ASN LEU SEQRES 4 B 259 PRO VAL ILE LYS ARG PRO VAL GLY PRO PRO LYS PHE LEU SEQRES 5 B 259 ARG VAL ASN LEU LYS ALA SER THR GLY THR VAL SER LEU SEQRES 6 B 259 ALA VAL GLN ARG SER ASN LEU TYR VAL ALA ALA TYR LEU SEQRES 7 B 259 ALA LYS ASN ASN ASN LYS GLN PHE ARG ALA TYR TYR PHE SEQRES 8 B 259 LYS GLY PHE GLN ILE THR THR ASN GLN LEU ASN ASN LEU SEQRES 9 B 259 PHE PRO GLU ALA THR GLY VAL SER ASN GLN GLN GLU LEU SEQRES 10 B 259 GLY TYR GLY GLU SER TYR PRO GLN ILE GLN ASN ALA ALA SEQRES 11 B 259 GLY VAL THR ARG GLN GLN ALA GLY LEU GLY ILE LYS LYS SEQRES 12 B 259 LEU ALA GLU SER MET THR LYS VAL ASN GLY VAL ALA ARG SEQRES 13 B 259 VAL GLU LYS ASP GLU ALA LEU PHE LEU LEU ILE VAL VAL SEQRES 14 B 259 GLN MET VAL GLY GLU ALA ALA ARG PHE LYS TYR ILE GLU SEQRES 15 B 259 ASN LEU VAL LEU ASN ASN PHE ASP THR ALA LYS GLU VAL SEQRES 16 B 259 GLU PRO VAL PRO ASP ARG VAL ILE ILE LEU GLU ASN ASN SEQRES 17 B 259 TRP GLY LEU LEU SER ARG ALA ALA LYS THR ALA ASN ASN SEQRES 18 B 259 GLY VAL PHE GLN THR PRO LEU VAL LEU THR SER TYR ALA SEQRES 19 B 259 VAL PRO GLY VAL GLU TRP ARG VAL THR THR VAL ALA GLU SEQRES 20 B 259 VAL GLU ILE GLY ILE PHE LEU ASN VAL ASP ASN ASN HET TXN A 260 75 HET TXN B 260 75 HETNAM TXN (2R,3R,4R,5R)-5-(2-AMINO-6-OXO-3,6-DIHYDRO-9H-PURIN-9- HETNAM 2 TXN YL)-2-({[(S)-({(3R,4R)-4-({[(S)-{[(2R,3R,4R,5R)-5-(2- HETNAM 3 TXN AMINO-6-OXO-6,8-DIHYDRO-9H-PURIN-9-YL)-2- HETNAM 4 TXN (HYDROXYMETHYL)-4-METHOXYTETRAHYDROFURAN-3- HETNAM 5 TXN YL]OXY}(HYDROXY)PHOSPHORYL]OXY}METHYL)-1-[(4-AMINO-5H- HETNAM 6 TXN PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]PYRROLIDIN-3- HETNAM 7 TXN YL}OXY)(HYDROXY)PHOSPHORYL]OXY}METHYL)-4- HETNAM 8 TXN METHOXYTETRAHYDROFURAN-3-YL 3-HYDROXYPROPYL HYDROGEN HETNAM 9 TXN (S)-PHOSPHATE FORMUL 3 TXN 2(C37 H52 N15 O20 P3) FORMUL 5 HOH *92(H2 O) HELIX 1 1 THR A 12 LYS A 28 1 17 HELIX 2 2 THR A 97 PHE A 105 1 9 HELIX 3 3 PRO A 106 THR A 109 5 4 HELIX 4 4 GLY A 110 SER A 112 5 3 HELIX 5 5 SER A 122 GLY A 131 1 10 HELIX 6 6 THR A 133 GLY A 138 1 6 HELIX 7 7 GLY A 140 THR A 149 1 10 HELIX 8 8 VAL A 157 PHE A 178 1 22 HELIX 9 9 PHE A 178 ASN A 188 1 11 HELIX 10 10 PRO A 199 ASN A 207 1 9 HELIX 11 11 ASN A 208 THR A 218 1 11 HELIX 12 12 ALA A 246 GLU A 249 5 4 HELIX 13 13 THR B 12 LYS B 28 1 17 HELIX 14 14 THR B 97 PHE B 105 1 9 HELIX 15 15 PRO B 106 THR B 109 5 4 HELIX 16 16 GLY B 110 SER B 112 5 3 HELIX 17 17 SER B 122 GLY B 131 1 10 HELIX 18 18 THR B 133 GLY B 138 1 6 HELIX 19 19 GLY B 140 THR B 149 1 10 HELIX 20 20 VAL B 157 VAL B 172 1 16 HELIX 21 21 VAL B 172 PHE B 178 1 7 HELIX 22 22 PHE B 178 ASN B 188 1 11 HELIX 23 23 PRO B 199 ASN B 207 1 9 HELIX 24 24 ASN B 208 THR B 218 1 11 HELIX 25 25 ALA B 246 GLU B 249 5 4 SHEET 1 A 6 ILE A 3 ASN A 7 0 SHEET 2 A 6 PHE A 51 LYS A 57 1 O ARG A 53 N TYR A 4 SHEET 3 A 6 THR A 62 GLN A 68 -1 O VAL A 63 N LEU A 56 SHEET 4 A 6 VAL A 74 LYS A 80 -1 O ALA A 75 N ALA A 66 SHEET 5 A 6 PHE A 86 TYR A 90 -1 O TYR A 89 N TYR A 77 SHEET 6 A 6 GLN A 114 GLU A 116 1 O GLN A 115 N ALA A 88 SHEET 1 B 2 VAL A 223 LEU A 230 0 SHEET 2 B 2 TRP A 240 THR A 244 -1 O TRP A 240 N LEU A 230 SHEET 1 C 6 ILE B 3 ASN B 7 0 SHEET 2 C 6 PHE B 51 ALA B 58 1 O ASN B 55 N TYR B 4 SHEET 3 C 6 GLY B 61 GLN B 68 -1 O VAL B 63 N LEU B 56 SHEET 4 C 6 VAL B 74 LYS B 80 -1 O ALA B 75 N ALA B 66 SHEET 5 C 6 PHE B 86 TYR B 90 -1 O TYR B 89 N TYR B 77 SHEET 6 C 6 GLN B 114 GLU B 116 1 O GLN B 115 N ALA B 88 SHEET 1 D 2 VAL B 223 LEU B 230 0 SHEET 2 D 2 TRP B 240 THR B 244 -1 O VAL B 242 N LEU B 228 CISPEP 1 ARG A 44 PRO A 45 0 1.41 CISPEP 2 GLY A 47 PRO A 48 0 -2.94 CISPEP 3 PRO A 48 PRO A 49 0 -2.06 CISPEP 4 GLU A 196 PRO A 197 0 -0.04 CISPEP 5 ARG B 44 PRO B 45 0 -4.22 CISPEP 6 GLY B 47 PRO B 48 0 1.83 CISPEP 7 PRO B 48 PRO B 49 0 -2.58 CISPEP 8 GLU B 196 PRO B 197 0 -9.12 SITE 1 AC1 24 ASN A 71 LEU A 72 TYR A 73 VAL A 74 SITE 2 AC1 24 PHE A 94 GLU A 121 TYR A 123 PRO A 124 SITE 3 AC1 24 GLU A 174 ARG A 177 GLU A 206 ASN A 207 SITE 4 AC1 24 TRP A 209 GLY A 210 ARG A 214 TYR A 233 SITE 5 AC1 24 LEU A 254 HOH A 261 HOH A 270 HOH A 302 SITE 6 AC1 24 THR B 231 SER B 232 TYR B 233 HOH B 272 SITE 1 AC2 23 THR A 231 SER A 232 TYR A 233 ASN B 71 SITE 2 AC2 23 LEU B 72 TYR B 73 VAL B 74 PHE B 94 SITE 3 AC2 23 GLU B 121 SER B 122 TYR B 123 PRO B 124 SITE 4 AC2 23 GLU B 174 ARG B 177 GLU B 206 ASN B 207 SITE 5 AC2 23 TRP B 209 GLY B 210 ARG B 214 TYR B 233 SITE 6 AC2 23 LEU B 254 HOH B 262 HOH B 263 CRYST1 50.329 52.884 54.239 79.41 66.46 80.67 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019869 -0.003264 -0.008299 0.00000 SCALE2 0.000000 0.019163 -0.002543 0.00000 SCALE3 0.000000 0.000000 0.020287 0.00000